# A Study of DM005 in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct06515990/  
OnCo record `nct06515990` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of DM005 in non-small-cell lung cancer and head and neck squamous cell carcinoma, run by Doma Biopharmaceutical（Suzhou）Co., Ltd., now recruiting.

## Summary

A Study of DM005 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06515990 by Doma Biopharmaceutical（Suzhou）Co., Ltd., with 208 participants planned, started 2024-10-31 and due to reach its primary completion in 2027-03. Interventions recorded: DM005.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06515990
- Phase: 1/2
- Setting: A Phase I/IIa, Multicenter, Open-label, First-in-human, Dose Escalation and Expansion Study of DM005 in Patients With Advanced Solid Tumors
- Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd.
- Enrolled: 208

## Sources

- ClinicalTrials.gov NCT06515990: https://clinicaltrials.gov/study/NCT06515990

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)

---
JSON: https://onco.cc/api/v1/entities/nct06515990.json